| Trial ID: | L0574 |
| Source ID: | IRCT2016071915536N3
|
| Associated Drug: |
Nanocurcumin
|
| Title: |
The clinical trial of effects of nanocurcumin supplementation on blood nesfatin, insulin resistance indexes, lipids and inflammatory factors in overweight and obese patients with non-alcoholic fatty liver disease ??(NAFLD)?
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non alcoholic fatty liver disease. <br>Nonalcoholic steatohepatitis, Nonalcoholic fatty liver disease;K75.8, K76;Nonalcoholic steatohepatitis, Nonalcoholic fatty liver disease
|
| Interventions: |
Intervention 1: Intervention Group: Nanocurcumin supplementation with dose of 80mg (40mg bid with breakfast and dinner meals) for 3 months. Intervention 2: Placebo Group: Placebo supplementation with dose of 80mg (40mg bid with breakfast and dinner meals)
|
| Outcome Measures: |
Nesfatin. Timepoint: At the beginning and end of intervention. Method of measurement: serum levels (ng/ml?) by Elisa.ALT/AST/TG/TC/HDL/LDL/FBS/FBI/HbA1C/TNF-Alpha/IL-6/hs-CRP. Timepoint: At the beginning and end of intervention. Method of measurement: Serum levels by Elisa.;Blood pressure, Body composition, Body Mass Iindex, Waist Circumference. Timepoint: At the beginning and end of intervention. Method of measurement: Mercury manometer, BIA, Formula, Tape measure (mmhg, %, kg/m2, cm), respectively.
|
| Sponsor/Collaborators: |
Vice chancellor for research, Tehran University of Medical Sciences
|
| Gender: |
All
|
| Age: |
25 years50 years
|
| Phases: |
Not applicable
|
| Enrollment: |
84
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: Block randomization.
|
| Start Date: |
02/08/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/14784
|
